Product NDC: | 67767-202 |
Proprietary Name: | Methylphenidate Hydrochloride |
Non Proprietary Name: | Methylphenidate Hydrochloride |
Active Ingredient(s): | 40 mg/1 & nbsp; Methylphenidate Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67767-202 |
Labeler Name: | Actavis South Atlantic LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078458 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120103 |
Package NDC: | 67767-202-01 |
Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (67767-202-01) |
NDC Code | 67767-202-01 |
Proprietary Name | Methylphenidate Hydrochloride |
Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (67767-202-01) |
Product NDC | 67767-202 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Methylphenidate Hydrochloride |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20120103 |
Marketing Category Name | ANDA |
Labeler Name | Actavis South Atlantic LLC |
Substance Name | METHYLPHENIDATE HYDROCHLORIDE |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |